| Product NDC: | 61570-037 |
| Proprietary Name: | VIROPTIC |
| Non Proprietary Name: | trifluridine |
| Active Ingredient(s): | 1 g/100mL & nbsp; trifluridine |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61570-037 |
| Labeler Name: | Monarch Pharmaceuticals, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018299 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19800410 |
| Package NDC: | 61570-037-75 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (61570-037-75) > 7.5 mL in 1 BOTTLE, DROPPER |
| NDC Code | 61570-037-75 |
| Proprietary Name | VIROPTIC |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (61570-037-75) > 7.5 mL in 1 BOTTLE, DROPPER |
| Product NDC | 61570-037 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | trifluridine |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19800410 |
| Marketing Category Name | NDA |
| Labeler Name | Monarch Pharmaceuticals, Inc |
| Substance Name | TRIFLURIDINE |
| Strength Number | 1 |
| Strength Unit | g/100mL |
| Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |